SCHEMBL29615558

SCHEMBL29615558

Nc1cc(OCCCN2CCOCC2)ccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.57
ALDH1A1 P00352 4/20 0.57
MAPK1 P28482 2/20 0.57
SIGMAR1 Q99720 2/20 0.57
CYP1A2 P05177 1/20 0.57
CHRM2 P08172 1/20 0.57
CHRM1 P11229 1/20 0.57
HTR2A P28223 1/20 0.57
SCN1A P35498 1/20 0.57
HTR2B P41595 1/20 0.57
KCNH2 Q12809 1/20 0.57
SCN2A Q99250 1/20 0.57
SCN3A Q9NY46 1/20 0.57
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
KDM4E B2RXH2 1/20 0.53
HTT P42858 1/20 0.53
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22918726 1.00 HRH3 (0.57) HRH3ALDH1A1MAPK1SIGMAR1CYP1A2
SCHEMBL2024990 0.93 KDM4E (0.58) ALDH1A1CYP1A2KDM4ETSHRNPC1
SCHEMBL29615193 0.93 KDM4E (0.58) ALDH1A1CYP1A2KDM4ETSHRNPC1
SCHEMBL29615450 0.87 HRH3 (0.54) HRH3SIGMAR1KCNH2KDM4E
SCHEMBL22918759 0.87 HRH3 (0.54) HRH3SIGMAR1KCNH2KDM4E
SCHEMBL22918755 0.84 HRH3 (0.58) HRH3ALDH1A1SIGMAR1USP2KDM4E
SCHEMBL15260249 0.83 ALDH1A1 (0.57) HRH3ALDH1A1MAPK1SIGMAR1CYP1A2
SCHEMBL22918968 0.80 PDK2 (0.45) HRH3ALDH1A1MAPK1SIGMAR1CYP1A2
SCHEMBL29615306 0.80 PDK2 (0.45) HRH3ALDH1A1MAPK1SIGMAR1CYP1A2
SCHEMBL22919001 0.80 LTA4H (0.57) ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174293-A 4- (imidazo [1,2-a ] pyridin-3-yl) -pyrimidine derivatives 默克专利股份公司 2022-03-11 CN disclosed